The BAG groups 10 teams from 6 Marseille laboratories. Mutual understanding amongst all PIs provides a solid base for efficient organization of the BAG. Research revolves around infection, health and biotechnology. For the next beam time allocation period (6 months) we could make efficient use of 12 MX and 2 SAXS shifts. Three teams combine structural biology with medicinal chemistry and beam time at MASSIF for large ligand-screening campaigns will mostly suit their purpose. Access to beamlines with tunable energy will be instrumental for projects requiring experimental phasing. One team uses exclusively Bio-SAXS. Allocation of one shift per session would be welcomed. Remote access for MX sessions has become very popular whereas scientists prefer to be on-site for Bio-SAXS experiments.